{"transactions":[{"id":1839967,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:55:45.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077651","document":"tm2320411-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077651/tm2320411-2_4seq1.xml","form_type":"4"}},{"id":1839966,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:55:45.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":39415,"source":{"system":"sec-edgar","filing":"0001104659-23-077651","document":"tm2320411-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077651/tm2320411-2_4seq1.xml","form_type":"4"}},{"id":2230349,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:11:09.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071893","document":"tm2218645-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071893/tm2218645-2_4seq1.xml","form_type":"4"}},{"id":2230348,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:11:09.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":18196,"source":{"system":"sec-edgar","filing":"0001104659-22-071893","document":"tm2218645-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071893/tm2218645-2_4seq1.xml","form_type":"4"}},{"id":2631832,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-16T16:02:21.000Z","date":"2021-07-14","kind":"exercise","acquired":false,"shares":11108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option were fully vested as of the date of the exercise."}],"balance_after":0,"derivative":{"exercise_price":11.33,"expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":11108},"source":{"system":"sec-edgar","filing":"0001567619-21-013567","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921013567/doc1.xml","form_type":"4"}},{"id":2631831,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-16T16:02:21.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":2000,"price":56.1315,"value":112263.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $56.005 to $56.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-013567","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921013567/doc1.xml","form_type":"4"}},{"id":2631830,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-16T16:02:21.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":9108,"price":55.3093,"value":503757.1044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $55.00 to $55.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001567619-21-013567","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921013567/doc1.xml","form_type":"4"}},{"id":2631829,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-16T16:02:21.000Z","date":"2021-07-14","kind":"exercise","acquired":true,"shares":11108,"price":11.33,"value":125853.64,"ownership":{"direct":true},"balance_after":11108,"source":{"system":"sec-edgar","filing":"0001567619-21-013567","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921013567/doc1.xml","form_type":"4"}},{"id":2634743,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":6392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares subject to the option were fully vested as of the date of the exercise."}],"balance_after":11108,"derivative":{"exercise_price":11.33,"expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":6392},"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634742,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares subject to the option were fully vested as of the date of the exercise."}],"balance_after":0,"derivative":{"exercise_price":9.23,"expiration_date":"2029-05-22","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634741,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":177,"price":61.25,"value":10841.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634740,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":300,"price":59.4467,"value":17834.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The transaction was executed in multiple trades in prices ranging from $59.39 to $59.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":177,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634739,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":800,"price":58.655,"value":46924.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The transaction was executed in multiple trades in prices ranging from $58.34 to $59.18, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":477,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634738,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":700,"price":57.8543,"value":40498.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The transaction was executed in multiple trades in prices ranging from $57.34 to $58.21, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1277,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634737,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":2100,"price":56.5557,"value":118766.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transaction was executed in multiple trades in prices ranging from $56.00 to $56.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1977,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634736,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":2315,"price":55.2572,"value":127920.418,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades in prices ranging from $55.00 to $55.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4077,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634735,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":6392,"price":11.33,"value":72421.36,"ownership":{"direct":true},"balance_after":6392,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634734,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":177,"price":61.25,"value":10841.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634733,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":600,"price":59.245,"value":35547.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $59.12 to $59.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":177,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634732,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":500,"price":58.212,"value":29106.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $57.93 to $58.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":777,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634731,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":1634,"price":56.8751,"value":92933.9134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $56.53 to $57.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1277,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634730,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":2475,"price":55.9499,"value":138476.0025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $55.50 to $56.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":2911,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634729,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":5886,"price":54.554,"value":321104.844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $54.31 to $55.21, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":5386,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634728,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":6228,"price":53.843,"value":335334.204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The Reporting Person is filing this amendment to indicate that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $53.31 to $54.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":11272,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2634727,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-13T16:12:16.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":17500,"price":9.23,"value":161525.0,"ownership":{"direct":true},"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001140361-21-024235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024235/form4.xml","form_type":"4/A","original_submission_date":"2021-07-12"}},{"id":2635986,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":6392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares subject to the option were fully vested as of the date of the exercise."}],"balance_after":11108,"derivative":{"exercise_price":11.33,"expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":6392},"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635985,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares subject to the option were fully vested as of the date of the exercise."}],"balance_after":0,"derivative":{"exercise_price":9.23,"expiration_date":"2029-05-22","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635984,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":177,"price":61.25,"value":10841.25,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635983,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":300,"price":59.4467,"value":17834.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The transaction was executed in multiple trades in prices ranging from $59.39 to $59.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":177,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635982,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":800,"price":58.655,"value":46924.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The transaction was executed in multiple trades in prices ranging from $58.34 to $59.18, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":477,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635981,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":700,"price":57.8543,"value":40498.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The transaction was executed in multiple trades in prices ranging from $57.34 to $58.21, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1277,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635980,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":2100,"price":56.5557,"value":118766.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transaction was executed in multiple trades in prices ranging from $56.00 to $56.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1977,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635979,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":2315,"price":55.2572,"value":127920.418,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades in prices ranging from $55.00 to $55.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4077,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635978,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":6392,"price":11.33,"value":72421.36,"ownership":{"direct":true},"balance_after":6392,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635977,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":177,"price":61.25,"value":10841.25,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635976,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":600,"price":59.245,"value":35547.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $59.12 to $59.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":177,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635975,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":500,"price":58.212,"value":29106.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $57.93 to $58.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":777,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635974,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":1634,"price":56.8751,"value":92933.9134,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $56.53 to $57.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1277,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635973,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":2475,"price":55.9499,"value":138476.0025,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $55.50 to $56.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":2911,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635972,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":5886,"price":54.554,"value":321104.844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $54.31 to $55.21, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":5386,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635971,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":6228,"price":53.843,"value":335334.204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $53.31 to $54.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":11272,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2635970,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-07-12T21:37:00.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":17500,"price":9.23,"value":161525.0,"ownership":{"direct":true},"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001140361-21-024156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000114036121024156/form4.xml","form_type":"4"}},{"id":2651465,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T18:13:10.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option were fully vested as of the date of the exercise."}],"balance_after":0,"derivative":{"exercise_price":16.43,"expiration_date":"2028-05-16","underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-21-012739","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921012739/doc1.xml","form_type":"4"}},{"id":2651464,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-06-29T18:13:10.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":1736,"price":48.7308,"value":84596.6688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $48.23 to $49.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-012739","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921012739/doc1.xml","form_type":"4"}},{"id":2651463,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-06-29T18:13:10.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":10264,"price":47.5665,"value":488222.556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $47.18 to $48.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1736,"source":{"system":"sec-edgar","filing":"0001567619-21-012739","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921012739/doc1.xml","form_type":"4"}},{"id":2651462,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2021-06-29T18:13:10.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":12000,"price":16.43,"value":197160.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001567619-21-012739","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921012739/doc1.xml","form_type":"4"}},{"id":2664331,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:07:55.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":4748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":4748,"derivative":{"exercise_price":6.69,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":4748},"source":{"system":"sec-edgar","filing":"0001104659-21-082599","document":"tm2119990d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082599/tm2119990d3_4.xml","form_type":"4"}},{"id":2664330,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T20:07:55.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 2,374 restricted stock units on June 15, 2021, which shall vest in full on June 15, 2022."}],"balance_after":2374,"source":{"system":"sec-edgar","filing":"0001104659-21-082599","document":"tm2119990d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082599/tm2119990d3_4.xml","form_type":"4"}},{"id":2700605,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-21T17:02:40.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":23.97,"expiration_date":"2031-05-19","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-010951","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921010951/doc1.xml","form_type":"4"}},{"id":2853964,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T18:40:20.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":6315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017.  In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":6315,"derivative":{"exercise_price":22.85,"expiration_date":"2027-05-18","underlying":"Ordinary Shares","underlying_shares":6315},"source":{"system":"sec-edgar","filing":"0001567619-21-004308","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921004308/doc1.xml","form_type":"4"}},{"id":2853963,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T18:40:20.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017.  In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":56.23,"exercise_date":"2018-05-14","expiration_date":"2027-05-18","underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-21-004308","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921004308/doc1.xml","form_type":"4"}},{"id":2853962,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T18:40:20.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":8426,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016.  In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":8426,"derivative":{"exercise_price":22.85,"expiration_date":"2026-05-20","underlying":"Ordinary Shares","underlying_shares":8426},"source":{"system":"sec-edgar","filing":"0001567619-21-004308","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921004308/doc1.xml","form_type":"4"}},{"id":2853961,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T18:40:20.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016.  In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":42.5,"exercise_date":"2017-05-16","expiration_date":"2026-05-20","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-004308","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921004308/doc1.xml","form_type":"4"}},{"id":2853960,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T18:40:20.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":9803,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015.  In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":9803,"derivative":{"exercise_price":22.85,"expiration_date":"2025-05-22","underlying":"Ordinary Shares","underlying_shares":9803},"source":{"system":"sec-edgar","filing":"0001567619-21-004308","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921004308/doc1.xml","form_type":"4"}},{"id":2853959,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T18:40:20.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015.  In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":34.04,"exercise_date":"2016-05-18","expiration_date":"2025-05-22","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-004308","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761921004308/doc1.xml","form_type":"4"}},{"id":3097777,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-29T22:49:46.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":5200,"derivative":{"exercise_price":4.7,"exercise_date":"2021-06-25","expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001104659-20-078123","document":"tm2023597d4_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465920078123/tm2023597d4_form4.xml","form_type":"4"}},{"id":3136847,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-22T16:40:01.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":11.33,"expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001567619-20-011035","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761920011035/doc1.xml","form_type":"4"}},{"id":3506519,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-31T20:39:02.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":18750,"derivative":{"exercise_price":0.64,"exercise_date":"2020-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001144204-19-029258","document":"tv522822_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420419029258/tv522822_form4.xml","form_type":"4"}},{"id":3511525,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-24T16:07:08.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":9.23,"expiration_date":"2029-05-22","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001567619-19-012072","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000156761919012072/doc1.xml","form_type":"4"}},{"id":3908775,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T21:36:25.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":8576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":8576,"derivative":{"exercise_price":1.42,"exercise_date":"2019-05-31","expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":8576},"source":{"system":"sec-edgar","filing":"0001144204-18-032720","document":"tv495790_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420418032720/tv495790_form4.xml","form_type":"4"}},{"id":3925566,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-18T16:15:33.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2019 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":16.43,"expiration_date":"2028-05-16","underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-18-013415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924318013415/doc4.xml","form_type":"4"}},{"id":3998141,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-13T18:01:44.000Z","date":"2018-03-09","kind":"disposition_to_issuer","acquired":false,"shares":13927,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, the restricted stock units were cancelled in exchange for a cash payment of $139,270.00, which is the product of the total number of shares subject to such restricted stock unit grant multiplied by the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, the restricted stock units were cancelled in exchange for a cash payment of $139,270.00, which is the product of the total number of shares subject to such restricted stock unit grant multiplied by the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units were granted on June 9, 2017 and vest on the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units expire upon the earlier of the settlement of the units and the unitholder's termination of service."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":13927},"source":{"system":"sec-edgar","filing":"0000899243-18-007293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000089924318007293/doc4.xml","form_type":"4"}},{"id":3998140,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-03-13T18:01:44.000Z","date":"2018-03-09","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $91,000.00, which represents the product of (a) the difference between $10.00 and the exercise price of the option per share, multiplied by (b) the number of shares subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on the first anniversary of the grant date of March 16, 2016, and the remainder vest monthly thereafter for 36 months. All shares subject to this option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2026-03-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-18-007293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000089924318007293/doc4.xml","form_type":"4"}},{"id":3998139,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-13T18:01:44.000Z","date":"2018-03-09","kind":"other","acquired":false,"shares":60185,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Common Stock tendered in the tender offer launched by Valley Acquisition Sub, Inc. on February 8, 2018 pursuant to that certain Agreement and Plan of Merger, dated January 30, 2018, among Seattle Genetics, Inc., Valley Acquisition Sub, Inc., and Cascadian Therapeutics, Inc. (the \"Merger Agreement\"), to acquire all of the outstanding shares of common stock of Cascadian Therapeutics, Inc., par value $0.0001 per share, at a purchase price of $10.00 per share (\"Offer Price\"), net to the seller in cash, without interest and less any required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-007293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000089924318007293/doc4.xml","form_type":"4"}},{"id":4102854,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-09T06:32:03.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":84705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is granted pursuant to the Company's director compensation program and is for fiscal year ending December 31, 2018.  This option vests in 12 equal monthly installments.  The vesting commencement date is commensurate with the grant date of January 5, 2018."}],"balance_after":84705,"derivative":{"exercise_price":1.65,"expiration_date":"2028-01-05","underlying":"Common Stock","underlying_shares":84705},"source":{"system":"sec-edgar","filing":"0001214659-18-000287","document":"marketforms-40684.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000121465918000287/marketforms-40684.xml","form_type":"4"}},{"id":4102853,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-09T06:32:03.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":84705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is granted pursuant to the Company's director compensation program and is for fiscal year ending December 31, 2017.  This option vests in 12 equal monthly installments.  The vesting commencement date is April 27, 2017."}],"balance_after":84705,"derivative":{"exercise_price":1.65,"expiration_date":"2028-01-05","underlying":"Common Stock","underlying_shares":84705},"source":{"system":"sec-edgar","filing":"0001214659-18-000287","document":"marketforms-40684.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000121465918000287/marketforms-40684.xml","form_type":"4"}},{"id":4199047,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-29T17:15:22.000Z","date":"2017-09-28","kind":"exercise","acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":14100,"derivative":{"exercise_price":6.65,"expiration_date":"2023-03-18","underlying":"Ordinary Shares","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0000899243-17-022965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317022965/doc4.xml","form_type":"4"}},{"id":4199046,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-09-29T17:15:22.000Z","date":"2017-09-28","kind":"sale","acquired":false,"shares":900,"price":70,"value":63000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-022965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317022965/doc4.xml","form_type":"4"}},{"id":4199045,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-09-29T17:15:22.000Z","date":"2017-09-28","kind":"exercise","acquired":true,"shares":900,"price":6.65,"value":5985.0,"ownership":{"direct":true},"balance_after":900,"source":{"system":"sec-edgar","filing":"0000899243-17-022965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317022965/doc4.xml","form_type":"4"}},{"id":4201471,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit (RSU)","published_at":"2017-09-26T17:19:15.000Z","date":"2017-09-24","kind":"exercise","acquired":false,"shares":2375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Approximately 75% of each RSU represents a contingent right to receive approximately 0.75 share of the issuer's Common Stock upon vesting and approximately 25% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU was 100% vested on September 24, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU was 100% vested on September 24, 2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2375},"source":{"system":"sec-edgar","filing":"0001209191-17-054013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117054013/doc4.xml","form_type":"4"}},{"id":4201470,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-26T17:19:15.000Z","date":"2017-09-24","kind":"tax_withholding","acquired":false,"shares":594,"price":3.94,"value":2340.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"594 shares of the restricted share unit (\"RSU\") grant, which represent approximately 25% of the shares underlying the RSU grant that vested on September 24, 2017, were not issued to the reporting holder; instead the reporting holder received an amount in cash from the issuer equal to the value of such shares based on the closing price of the issuer's Common Stock on September 22, 2017, the most recent date prior to the vesting date on which the issuer's Common Stock was traded, to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs, which transaction does not represent a sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"594 shares of the restricted share unit (\"RSU\") grant, which represent approximately 25% of the shares underlying the RSU grant that vested on September 24, 2017, were not issued to the reporting holder; instead the reporting holder received an amount in cash from the issuer equal to the value of such shares based on the closing price of the issuer's Common Stock on September 22, 2017, the most recent date prior to the vesting date on which the issuer's Common Stock was traded, to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs, which transaction does not represent a sale by the reporting person."}],"balance_after":60185,"source":{"system":"sec-edgar","filing":"0001209191-17-054013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117054013/doc4.xml","form_type":"4"}},{"id":4201469,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-26T17:19:15.000Z","date":"2017-09-24","kind":"exercise","acquired":true,"shares":2375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60779,"source":{"system":"sec-edgar","filing":"0001209191-17-054013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117054013/doc4.xml","form_type":"4"}},{"id":4254391,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-19T16:10:53.000Z","date":"2017-07-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":15000,"derivative":{"exercise_price":6.65,"expiration_date":"2023-03-18","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-17-018555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317018555/doc4.xml","form_type":"4"}},{"id":4254390,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-07-19T16:10:53.000Z","date":"2017-07-17","kind":"sale","acquired":false,"shares":5000,"price":66.1341,"value":330670.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $66.00 to $66.30, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-018555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317018555/doc4.xml","form_type":"4"}},{"id":4254389,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-07-19T16:10:53.000Z","date":"2017-07-17","kind":"exercise","acquired":true,"shares":5000,"price":6.65,"value":33250.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-17-018555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317018555/doc4.xml","form_type":"4"}},{"id":4271634,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit (RSU)","published_at":"2017-06-27T17:39:25.000Z","date":"2017-06-24","kind":"exercise","acquired":false,"shares":9058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Approximately 75% of each RSU represents a contingent right to receive approximately 0.75 share of the issuer's Common Stock upon vesting and approximately 25% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU was 100% vested on June 24, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU was 100% vested on June 24, 2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9058},"source":{"system":"sec-edgar","filing":"0001209191-17-042005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117042005/doc4.xml","form_type":"4"}},{"id":4271633,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T17:39:25.000Z","date":"2017-06-24","kind":"tax_withholding","acquired":false,"shares":2265,"price":3.78,"value":8561.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2,265 shares of the restricted share unit (\"RSU\") grant, which represent approximately 25% of the shares underlying the RSU grant that vested on June 24, 2017, were not issued to the reporting holder; instead the reporting holder received an amount in cash from the issuer equal to the value of such shares based on the closing price of the issuer's Common Stock on June 23, 2017, the most recent date prior to the vesting date on which the issuer's Common Stock was traded, to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs, which transaction does not represent a sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"2,265 shares of the restricted share unit (\"RSU\") grant, which represent approximately 25% of the shares underlying the RSU grant that vested on June 24, 2017, were not issued to the reporting holder; instead the reporting holder received an amount in cash from the issuer equal to the value of such shares based on the closing price of the issuer's Common Stock on June 23, 2017, the most recent date prior to the vesting date on which the issuer's Common Stock was traded, to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs, which transaction does not represent a sale by the reporting person."}],"balance_after":58404,"source":{"system":"sec-edgar","filing":"0001209191-17-042005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117042005/doc4.xml","form_type":"4"}},{"id":4271632,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-27T17:39:25.000Z","date":"2017-06-24","kind":"exercise","acquired":true,"shares":9058,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60669,"source":{"system":"sec-edgar","filing":"0001209191-17-042005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117042005/doc4.xml","form_type":"4"}},{"id":4283567,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit (RSU)","published_at":"2017-06-13T16:39:09.000Z","date":"2017-06-12","kind":"exercise","acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Approximately 75% of each RSU represents a contingent right to receive approximately 0.75 share of the issuer's Common Stock upon vesting and approximately 25% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU was 100% vested on June 12, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU was 100% vested on June 12, 2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001209191-17-039497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117039497/doc4.xml","form_type":"4"}},{"id":4283566,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit (RSU)","published_at":"2017-06-13T16:39:09.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":13927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Approximately 75% of each RSU represents a contingent right to receive approximately 0.75 share of the issuer's Common Stock upon vesting and approximately 25% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% vests on the one-year anniversary of the Transaction Date, subject to acceleration under certain circumstances."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% vests on the one-year anniversary of the Transaction Date, subject to acceleration under certain circumstances."}],"balance_after":13927,"derivative":{"underlying":"Common Stock","underlying_shares":13927},"source":{"system":"sec-edgar","filing":"0001209191-17-039497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117039497/doc4.xml","form_type":"4"}},{"id":4283565,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-13T16:39:09.000Z","date":"2017-06-12","kind":"tax_withholding","acquired":false,"shares":537,"price":3.34,"value":1793.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"537 shares of the restricted share unit (\"RSU\") grant, which represent approximately 25% of the shares underlying the RSU grant that vested on June 12, 2017, were not issued to the reporting holder; instead the reporting holder received an amount in cash from the issuer equal to the value of such shares based on the closing price of the issuer's Common Stock on June 12, 2017 to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs, which transaction does not represent a sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"537 shares of the restricted share unit (\"RSU\") grant, which represent approximately 25% of the shares underlying the RSU grant that vested on June 12, 2017, were not issued to the reporting holder; instead the reporting holder received an amount in cash from the issuer equal to the value of such shares based on the closing price of the issuer's Common Stock on June 12, 2017 to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs, which transaction does not represent a sale by the reporting person."}],"balance_after":51611,"source":{"system":"sec-edgar","filing":"0001209191-17-039497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117039497/doc4.xml","form_type":"4"}},{"id":4283564,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-13T16:39:09.000Z","date":"2017-06-12","kind":"exercise","acquired":true,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52148,"source":{"system":"sec-edgar","filing":"0001209191-17-039497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117039497/doc4.xml","form_type":"4"}},{"id":4298303,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-01T21:04:54.000Z","date":"2017-05-30","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":2000,"derivative":{"exercise_price":4.38,"exercise_date":"2018-05-30","expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001571049-17-005585","document":"t1701732_x3-f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000157104917005585/t1701732_x3-f4.xml","form_type":"4"}},{"id":4311528,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-19T16:07:00.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2018 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":56.23,"expiration_date":"2027-05-18","underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-17-013899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317013899/doc4.xml","form_type":"4"}},{"id":4413635,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option\n(right to buy)","published_at":"2017-03-01T16:05:53.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":5989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":20000,"derivative":{"exercise_price":6.65,"expiration_date":"2023-03-18","underlying":"Ordinary Shares","underlying_shares":5989},"source":{"system":"sec-edgar","filing":"0000899243-17-005786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317005786/doc4.xml","form_type":"4"}},{"id":4413634,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-03-01T16:05:53.000Z","date":"2017-02-27","kind":"sale","acquired":false,"shares":5989,"price":57.1632,"value":342350.4048,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $57.00 to $57.80, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-005786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317005786/doc4.xml","form_type":"4"}},{"id":4413633,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-03-01T16:05:53.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":5989,"price":6.65,"value":39826.85,"ownership":{"direct":true},"balance_after":5989,"source":{"system":"sec-edgar","filing":"0000899243-17-005786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317005786/doc4.xml","form_type":"4"}},{"id":4431056,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-22T17:05:33.000Z","date":"2017-02-17","kind":"exercise","acquired":false,"shares":4011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":25989,"derivative":{"exercise_price":6.65,"expiration_date":"2023-03-18","underlying":"Ordinary Shares","underlying_shares":4011},"source":{"system":"sec-edgar","filing":"0000899243-17-004967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317004967/doc4.xml","form_type":"4"}},{"id":4431055,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-02-22T17:05:33.000Z","date":"2017-02-17","kind":"sale","acquired":false,"shares":4011,"price":57.0632,"value":228880.4952,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $57.00 to $57.26, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-004967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317004967/doc4.xml","form_type":"4"}},{"id":4431054,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-02-22T17:05:33.000Z","date":"2017-02-17","kind":"exercise","acquired":true,"shares":4011,"price":6.65,"value":26673.15,"ownership":{"direct":true},"balance_after":4011,"source":{"system":"sec-edgar","filing":"0000899243-17-004967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000089924317004967/doc4.xml","form_type":"4"}},{"id":4457087,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit (RSU)","published_at":"2017-02-10T16:40:21.000Z","date":"2016-06-06","kind":"exercise","acquired":false,"shares":2723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Approximately 75% of each RSU represents a contingent right to receive approximately 0.75 share of the issuer's Common Stock upon vesting and approximately 25% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective as of November 29, 2016, the issuer effected a 6-for-1 reverse split of its common stock.  The number of shares above reflects the reverse stock split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSU was 100% vested on June 6, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSU was 100% vested on June 6, 2016."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2723},"source":{"system":"sec-edgar","filing":"0001209191-17-009563","document":"doc5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117009563/doc5.xml","form_type":"5"}},{"id":4457086,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-10T16:40:21.000Z","date":"2016-06-06","kind":"tax_withholding","acquired":false,"shares":681,"price":7.38,"value":5025.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"681 shares (which number reflects post-reverse split shares) of the restricted share unit (\"RSU\") grant, which represent approximately 25% of the shares underlying the RSU grant that vested on June 6, 2016, were not issued to the reporting holder; instead the reporting holder received an amount in cash from the issuer equal to the value of such shares based on the closing price of the issuer's Common Stock on June 6, 2016, the most recent date prior to the vesting date on which the issuer's Common Stock was traded, to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs, which transaction does not represent a sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"681 shares (which number reflects post-reverse split shares) of the restricted share unit (\"RSU\") grant, which represent approximately 25% of the shares underlying the RSU grant that vested on June 6, 2016, were not issued to the reporting holder; instead the reporting holder received an amount in cash from the issuer equal to the value of such shares based on the closing price of the issuer's Common Stock on June 6, 2016, the most recent date prior to the vesting date on which the issuer's Common Stock was traded, to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs, which transaction does not represent a sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Effective as of November 29, 2016, the issuer effected a 6-for-1 reverse split of its common stock.  The price above reflects the reverse stock split."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-17-009563","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117009563/doc5.xml","form_type":"5"}},{"id":4457085,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-10T16:40:21.000Z","date":"2016-06-06","kind":"exercise","acquired":true,"shares":2723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective as of November 29, 2016, the issuer effected a 6-for-1 reverse split of its common stock.  The number of shares above reflects the reverse stock split."}],"balance_after":50861,"source":{"system":"sec-edgar","filing":"0001209191-17-009563","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117009563/doc5.xml","form_type":"5"}},{"id":4473404,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-01T16:38:12.000Z","date":"2017-01-30","kind":"purchase","acquired":true,"shares":25324,"price":4.1057,"value":103972.7468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price per share.  The shares sold at prices ranging from $3.8047 to $4.14 per share.  Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-17-006724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919117006724/doc4.xml","form_type":"4"}},{"id":4528462,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-12-08T18:52:11.000Z","date":"2016-12-08","kind":"grant","acquired":true,"shares":83910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of December 8, 2016. This stock option is fully exercisable on December 8, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of December 8, 2016. This stock option is fully exercisable on December 8, 2017."}],"balance_after":83910,"derivative":{"exercise_price":2,"expiration_date":"2026-12-08","underlying":"Common Stock","underlying_shares":83910},"source":{"system":"sec-edgar","filing":"0001214659-16-015273","document":"marketforms-37333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242880/000121465916015273/marketforms-37333.xml","form_type":"4"}}]}